Richard Burr: “We've learned, in Washington, if it's printed in the paper, it must be fact.”

Without Orrin, we wouldn't have a generic drug industry.

More than 278 therapies have been approved under the accelerated approval pathway over the 30 year history, saving and improving thousands of lives.

What does it mean for a small company when FDA misses these goals, and what does it mean to patients?

I went through a litany in my opening statements of the deficiencies in what FDA committed to and what they missed.